Ca2+ inhibits the association of memantine with N-methyl-D-aspartate (NMDA) receptor-gated ion channels

被引:3
作者
Fujimoto, Masafumi [1 ]
Iida, Hirokazu [2 ]
Homma, Tomoo [3 ]
Kimura, Ikuo [1 ]
Mori, Masahiro [1 ]
Hamana, Hiroshi [2 ]
机构
[1] Chiba Inst Sci, Fac Pharmaceut Sci, Lab Appl Pharmacol, Chiba 2880025, Japan
[2] Chiba Inst Sci, Fac Pharmaceut Sci, Organ Chem Lab, Chiba 2880025, Japan
[3] Chiba Inst Sci, Fac Risk & Crisis Management, Dept Environm Syst Sci, Chiba 2880025, Japan
关键词
memantine; N-methyl-D-aspartate receptor-gated ion channel; calcium ion; (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801);
D O I
10.1248/bpb.31.1813
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We examined the effect of 1-amino-3,5-dimethyladamantane (memantine) and (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801) on the inhibition of [H-3]MK-801 binding to crude synaptic membranes of rat forebrains in the absence or presence of Ca2+. Ca2+ decreased the potency of memantine to inhibit [H-3]MK-801 binding. The effect of Ca2+ was apparently competitive with memantine and was not annulled by the addition of Mg2+. Ca2+ slightly enhanced [H-3]MK-801 binding, but showed no effect on the displacement of [H-3]MK-801 binding by MK-801. The Ca2+-sensitive interaction of memantine with N-methyl-D-aspartate (NMDA) receptor-gated ion channels may provide a clue to understanding its voltage-dependent and clinically tolerated character.
引用
收藏
页码:1813 / 1815
页数:3
相关论文
共 50 条
  • [31] Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine
    Nicholson, KL
    Jones, HE
    Balster, RL
    BEHAVIOURAL PHARMACOLOGY, 1998, 9 (03): : 231 - 243
  • [32] N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer's Disease, Vascular Dementia and Parkinson's Disease
    Olivares, David
    Deshpande, Varun K.
    Shi, Ying
    Lahiri, Debomoy K.
    Greig, Nigel H.
    Rogers, Jack T.
    Huang, Xudong
    CURRENT ALZHEIMER RESEARCH, 2012, 9 (06) : 746 - 758
  • [33] Effect of N-methyl-D-aspartate (NMDA) receptor antagonists on α-synuclein-evoked neuronal nitric oxide synthase activation in the rat brain
    Adamczyk, Agata
    Czapski, Grzegorz A.
    Kazmierczak, Anna
    Strosznajder, Joanna B.
    PHARMACOLOGICAL REPORTS, 2009, 61 (06) : 1078 - 1085
  • [34] Clinical Effectiveness of N-Methyl-D-Aspartate (NMDA) Receptor Antagonists in Adult Obsessive-Compulsive Disorder (OCD) Treatment: A Systematic Review
    Ferguson, Asila A.
    Khan, Aujala Irfan
    Abuzainah, Baraa
    Chaudhuri, Dipabali
    Khan, Kokab Irfan
    Al Shouli, Roba
    Allakky, Akhil
    Hamdan, Jaafar A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [35] Effects of N-methyl-D-aspartate receptor antagonists on cisplatin-induced emesis in the ferret
    Lehmann, A
    Karrberg, L
    NEUROPHARMACOLOGY, 1996, 35 (04) : 475 - 481
  • [36] Identification of N-methyl-D-aspartate receptor antagonists using the rat mixed cortical and neurons
    Voldrich, Jan
    Matousova, Marika
    Smidkova, Marketa
    Slavikova, Barbora
    Chodounska, Hana
    Kudova, Eva
    Mertlikova-Kaiserova, Helena
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 927
  • [37] Novel N-methyl-D-aspartate receptor antagonists: a review of compounds patented since 2006
    Koller, Manuel
    Urwyler, Stephan
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (12) : 1683 - 1702
  • [38] Differential effects of N-Methyl-D-aspartate receptor blockade on nociceptive somatic and visceral reflexes
    Olivar, T
    Laird, JMA
    PAIN, 1999, 79 (01) : 67 - 73
  • [39] Exploring the Therapeutic Potential of N-Methyl-D-Aspartate Receptor Antagonists in Neuropathic Pain Management
    Puscasu, Ciprian
    Chiria, Cornel
    Negres, Simona
    Blebea, Nicoleta Mirela
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (20)
  • [40] Potential Pharmacokinetic Drug-Drug Interaction Between Harmine, a Cholinesterase Inhibitor, and Memantine, a Non-Competitive N-Methyl-d-Aspartate Receptor Antagonist
    Zhang, Yunpeng
    Li, Shuping
    Wang, Youxu
    Deng, Gang
    Cao, Ning
    Wu, Chao
    Ding, Wenzheng
    Wang, Yuwen
    Cheng, Xuemei
    Wang, Changhong
    MOLECULES, 2019, 24 (07)